Neovasc to Present at the Leerink Partners Global Healthcare Conference
VANCOUVER, Feb. 15, 2017 /CNW/ – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that Alexei Marko, chief executive officer, is scheduled to present at the LEERINK Partners 6th Annual Global Healthcare Conference on Thursday, February 16th at 9:00 am ET at the Lotte New York Palace in New York City.
A live audio webcast of the presentation will be available on the Investors page of Neovasc’s website at www.neovasc.com.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™, for the treatment of refractory angina which is not currently available in the U.S. and has been available in Europe since 2015 and the Tiara™, for the transcatheter treatment of mitral valve disease, which is currently under investigation in the U.S., Canada and Europe. The Company also sells a line of advanced biological tissue products that are used as key components in third-party medical products including transcatheter heart valves. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.